Skip to content

Randomized Controlled Trial of Telehealth Management in Exercise and Health on Cardiovascular Health in Patients with Chronic Obstructive Pulmonary Disease

Study on the Impact of Pulmonary Rehabilitation and Exercise Intervention on Vascular Stiffness in High-Risk Populations with Stable Chronic Obstructive Pulmonary Disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110004
Enrollment
Unknown
Registered
2025-09-28
Start date
2025-09-30
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease and cardiovascular disease

Interventions

Intervention group 1:Conduct a 12-week inspiratory muscle training program at 30%–60% MIP using a decremental flow-resistive breathing trainer, elliptical machine, stationary bike, and shoulder press/
Intervention group 2:Conduct a 12-week inspiratory muscle training program at 30%–60% MIP, combined with aerobic (Western-style) and resistance training using an elliptical machine, stationary bike, a
Intervention group 3:Conduct a 12-week inspiratory muscle training program at 30%–60% MIP, combined with Chinese-style aerobic training and resistance training using an elliptical machine, stationary
Intervention group 4:Conduct a 12-week inspiratory muscle training program at 30%–60% MIP, combined with Chinese-style aerobic training (with remote monitoring) and resistance training using an ellipt

Sponsors

West China School of Public Health and West China Fourth Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. According to the American Thoracic Association (ATS)/Respiratory ERS standards, patients with FEV1/FVC= 1400mm/s; 4. Agree to participate in this experiment and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Has undergone pulmonary resection or lobectomy within the past 6 months; 2. Having pneumothorax or rib fractures; 3. Severe movement disorders (not caused by chronic obstructive pulmonary disease), or other neurological, muscular, skeletal, or cardiovascular diseases that seriously affect the safety of the subject's training; 4. Severe heart disease (acute heart failure or myocardial infarction, unstable angina, uncontrolled arrhythmia, third degree atrioventricular block patients, unexplained chest pain and palpitations); 5. Pregnancy or breastfeeding; 6. Individuals with cognitive impairment or other inability to cooperate with training; 7. Individuals who have not signed informed consent forms; 8. Participate in other similar experiments; 9. Strict inclusion and exclusion criteria will be applied to exclude subjects with a pulmonary bulla diameter greater than 1cm.

Design outcomes

Primary

MeasureTime frame
Degree of arteriosclerosis;Pulmonary function;

Secondary

MeasureTime frame
Lifestyle;Blood pressure;Blood fat;Blood sugar;Anthropometric measurements;Handgrip strength;Body composition;Electrocardiography (ECG);Carotid ultrasonography;6-minute walk test;Bone mineral density;Liver fibrosis measurement;Muscle strength test;

Countries

China

Contacts

Public ContactYang Shujuan

West Fourth Hospital, Sichuan University / West China School of Public Health

rekiny@126.com+86 189 8084 2145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026